BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25435431)

  • 1. Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology.
    Upheber S; Karle A; Miller J; Schlaugk S; Gross E; Reuning U
    Cell Signal; 2015 Mar; 27(3):652-62. PubMed ID: 25435431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
    Ruseva Z; Geiger PX; Hutzler P; Kotzsch M; Luber B; Schmitt M; Gross E; Reuning U
    Exp Cell Res; 2009 Jun; 315(10):1759-71. PubMed ID: 19371633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
    Lössner D; Abou-Ajram C; Benge A; Reuning U
    Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells.
    Miller J; Dreyer TF; Bächer AS; Sinner EK; Heinrich C; Benge A; Gross E; Preis S; Rother J; Roberts A; Nelles G; Miteva T; Reuning U
    Oncotarget; 2018 Jan; 9(5):6369-6390. PubMed ID: 29464079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.
    Lee JH; Seo YW; Park SR; Kim YJ; Kim KK
    Cancer Res; 2003 Nov; 63(21):7247-55. PubMed ID: 14612520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription.
    Lössner D; Abou-Ajram C; Benge A; Aumercier M; Schmitt M; Reuning U
    J Cell Physiol; 2009 Aug; 220(2):367-75. PubMed ID: 19334037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
    Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
    Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.
    Tang Y; Cheng Y; Martinka M; Ong CJ; Li G
    Carcinogenesis; 2014 Jan; 35(1):86-95. PubMed ID: 24130172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion.
    Beck V; Herold H; Benge A; Luber B; Hutzler P; Tschesche H; Kessler H; Schmitt M; Geppert HG; Reuning U
    Int J Biochem Cell Biol; 2005 Mar; 37(3):590-603. PubMed ID: 15618016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin αvβ3 promotes vitronectin gene expression in human ovarian cancer cells by implicating rel transcription factors.
    Reuning U
    J Cell Biochem; 2011 Jul; 112(7):1909-19. PubMed ID: 21433063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells.
    Reddy P; Liu L; Ren C; Lindgren P; Boman K; Shen Y; Lundin E; Ottander U; Rytinki M; Liu K
    Mol Endocrinol; 2005 Oct; 19(10):2564-78. PubMed ID: 15928314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KAI1/CD82 suppresses hepatocyte growth factor-induced migration of hepatoma cells via upregulation of Sprouty2.
    Mu Z; Wang H; Zhang J; Li Q; Wang L; Guo X
    Sci China C Life Sci; 2008 Jul; 51(7):648-54. PubMed ID: 18622748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction.
    Hapke S; Kessler H; Luber B; Benge A; Hutzler P; Höfler H; Schmitt M; Reuning U
    Biol Chem; 2003 Jul; 384(7):1073-83. PubMed ID: 12956424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of metastasis suppressor gene KAI1 on adhesion of hepatocellular carcinoma cell line MHCC97-H].
    Yu Y; Han DE; Liu W
    Ai Zheng; 2007 May; 26(5):498-503. PubMed ID: 17672940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
    Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
    Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer.
    Christgen M; Bruchhardt H; Ballmaier M; Krech T; Länger F; Kreipe H; Lehmann U
    Int J Cancer; 2008 Nov; 123(10):2239-46. PubMed ID: 18712725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the metastasis suppressor gene KAI1 in melanoma angiogenesis.
    Tang Y; Bhandaru M; Cheng Y; Lu J; Li G; Ong CJ
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):696-706. PubMed ID: 26199094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
    Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
    Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of KAI1/CD82 suppresses in vitro cell growth, migration, invasion and xenograft growth in oral cancer.
    Chai J; Du L; Ju J; Ma C; Shen Z; Yang X; Liang L; Ni Q; Sun M
    Mol Med Rep; 2017 Apr; 15(4):1527-1532. PubMed ID: 28260006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.